European paediatric non-alcoholic fatty liver disease registry (EU-PNAFLD): Design and rationale.
Jake P Mann, Anita Vreugdenhil, Piotr Socha...
https://pubmed.ncbi.nlm.nih.gov/30408605/Actively Recruiting
Led by Cambridge University Hospitals NHS Foundation Trust · Updated on 2022-03-04
2000
Participants Needed
3
Research Sites
N/A
Total Duration
The European Paediatric Non-Alcoholic Fatty Liver Disease Registry EU-PNAFLD brings together European centers caring for children with NAFLD, including hepatologists, endocrinologists, and scientists. This collaboration builds on existing databases and biorepositories, aligning with adult NAFLD registries to enable long-term follow-up and translational research. The study aims to support multi-center clinical trials, deepen understanding of NAFLD mechanisms, and establish the natural history of pediatric NAFLD. This observational registry includes children under 18 years diagnosed with NAFLD confirmed by imaging showing increased liver fat and excluding other causes. Diagnoses may also involve liver histology. The registry collects data over a long-term period, with up to 30 years of follow-up to monitor survival and disease progression. Participants will be followed longitudinally to assess outcomes such as survival, cardiovascular and liver morbidity, and asymptomatic liver disease progression. Data will come from clinical records, imaging, and laboratory results collected as part of routine care. This approach provides insight into the long-term impact of NAFLD in children and supports future research efforts.
CONDITIONS
European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD)
J
Jake P Mann, MRCPCH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Cambridge University Hospitals NHS Foundation Trust
Lead Sponsor
The European Association for the Study of the Liver
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 30 years
Participants with pediatric non-alcoholic fatty liver disease are followed over time to observe liver and cardiovascular health outcomes.
Regular follow-up visits over the course of the study
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Jake P Mann, Anita Vreugdenhil, Piotr Socha...
https://pubmed.ncbi.nlm.nih.gov/30408605/Cambridge University Hospitals NHS Foundation Trust
Lead Sponsor
The European Association for the Study of the Liver
Collaborating Sponsor